Zymeworks Inc. IPO Research Information

Zymeworks Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Zymeworks Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Zymeworks Inc.	ZYME - NYSE	$13.00-$16.00	$13.00	$13.50	4.5 million	4/28/2017
Underwriter(s): Citigroup, Barclays, Wells Fargo Securities,
Co-Manager(s): Canaccord Genuity, Cormark Securities (USA) Limited
Industry: Health Care
Filing(s): Filed 2017-04-03 Terms Added 2017-04-17

Zymeworks Inc. Quote & Chart - Click for current quote - ZYME

About Zymeworks Inc. (adapted from Zymeworks Inc. prospectus):
Zymeworks is an innovative, clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics, initially focused on the treatment of cancer.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "ZYME" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.